Navigation Links
Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date
Date:4/30/2009

CRANBURY, N.J., April 30 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) will announce first quarter 2009 financial results after the regular close of markets on Thursday, May 7, 2009. The results announcement will be followed by a live conference call and webcast that afternoon at 5 p.m. EDT.

Interested participants and investors may access the conference call at 5 p.m. EDT by dialing 877-874-1565 (U.S./Canada) or 719-325-4830 (international). A telephonic replay of the call will be available for seven days beginning at 8 p.m. EDT. Access numbers for this replay are 888-203-1112 (U.S./Canada) and 719-457-0820 (international); participant code 5114983.

An audio webcast can also be accessed via the investor section of the Amicus Therapeutics Web site at www.amicustherapeutics.com under Investors: Events and Presentations. Web participants are encouraged to go to the Web site 15 minutes prior to the start of the call to register, download and install any necessary software. After the live webcast, an audio webcast replay will remain available in the Investors section of the Amicus Therapeutics Web site for 30 days.

Amicus' press releases are available at www.amicustherapeutics.com.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs.

FOLD -G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
2. Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting
3. Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
4. Amicus Therapeutics Announces Change to Board of Directors
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
6. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
7. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
8. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
9. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
10. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
11. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... ... enable the world’s most progressive pharma and biotech organizations to do more clinical ... pharma and biotech events in Q4. , DrugDev will demonstrate DrugDev Spark™, the ...
(Date:9/20/2017)... ... September 20, 2017 , ... The award-winning ... Services (Koch) to feature new innovations aimed at helping farmers solve the problem ... American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... study examining the effects of exoskeleton-assisted walking on gait parameters and neuromuscular ... article, "Neuromechanical adaptations during a robotic powered exoskeleton assisted walking session" (doi:10.1080.10790268.2017.1314900) ...
(Date:9/19/2017)... ... , ... Participants of this educational webinar will learn the ... the advantages and disadvantages of ductless, filtered fume hoods, they will also discover ... Attendees will learn from an industry expert about the different types of ducted ...
Breaking Biology Technology:
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):